Regulators Approve Lenacapavir for H.I.V. Prevention
The drug could change the course of the AIDS epidemic. But the Trump administration has gutted the programs that might have paid for it in low-income countries.
Related Articles
Regulators Approve Lenacapavir for H.I.V. Prevention (Gift Article)
The drug could change the course of the AIDS epidemic. But the Trump administration has gutted the programs that might have paid for it in…
The world’s only twice-a-year shot to prevent HIV could stop transmission — if people can get it
WASHINGTON — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that could protect…
E.P.A. Plans to Reconsider a Ban on Cancer-Causing Asbestos (Gift Article)
The Trump administration’s move sets back a decades-long effort to end the use of the material, which is widely banned in other countries.
Meet the Anti-Vax ACIP First Round Draft Picks of 2025!
It’s MAHA fantasy season, so let’s take a look at this year’s rookie class. Which preventable disease will start killing children first?
Trump Travel Restrictions Bar Residents Needed at U.S. Hospitals
Limits on travel and visa appointments have delayed or prevented foreign doctors from entering the country for jobs set to begin in weeks.
Vaccine RCT spreadsheet aims to show the data, dispel myths about vaccines
University of Minnesota http://twin-cities.umn.edu/ 612-625-5000 Since late April, an infectious diseases specialist at Stanford University and his colleagues have been volunteering their time on a…
Opinion | The Return of the Great American Stomachache (Gift Article)
If Trump removes too many precautions, there’s a real chance that we’ll rediscover how dangerous a less regulated food system can be.
Reinforcing Support for Adolescent Girls and Young Women as PEPFAR Priorities Evolve | CSIS
Amid the dismantling and re-structuring of U.S. foreign assistance, policymakers can apply lessons from a decade of DREAMS programming to avert a resurgent HIV epidemic…
Clinical Evaluation of MAP-1 Antimicrobial Coating on Patient Privacy Curtains: Insights from a Randomized Trial in a Hong Kong Hospital
Microorganisms, including multidrug-resistant organisms (MDROs), can persist on hospital surfaces, posing significant health risks. Patient privacy curtains (PPCs) are particularly vulnerable due to their porous…
